Clopidogrel
生产企业：Dr reddys laboratories inc, Sanofi aventis us llc
Clopidogrel is an antiplatelet agent used to prevent blood clots in peripheral vascular disease, coronary artery disease, and cerebrovascular disease.
Clopidogrel is an antiplatelet agent used to prevent blood clots in peripheral vascular disease, coronary artery disease, and cerebrovascular disease.
Clopidogrel is metabolized to its active form by carboxylesterase-1. The active form is a platelet inhibitor that irreversibly binds to P2Y ADP receptors on platelets. This binding prevents ADP binding to P2Y receptors, activation of the glycoprotein GPIIb/IIIa complex, and platelet aggregation.
1.用于新近心肌梗死、新近脑卒中或确诊的周围动脉病变患者，可减少新的缺血性脑卒中、心肌梗死和死亡等心脑血管事件的符合终点； 2.用于急性冠状动脉综合征（不稳定心绞痛和非ST段抬高心肌梗死）患者； 3.用于冠状动脉支架置入术后预防支架内血栓形成（与阿司匹林联用）。
共 4 项相关疾病
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
